Trial Profile
Phase I study of VSN16R in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Mar 2015
Price :
$35
*
At a glance
- Drugs VSN 16R (Primary)
- Indications Multiple sclerosis; Muscle spasticity
- Focus Adverse reactions; First in man
- 02 Mar 2015 New trial record
- 24 Feb 2015 Results published in an Ipsen media release.